FDA Grants Emergency Authorization to Roche’s At-Home COVID-19 Test
FDA Sends Warning Letter to Medtronic About Diabetes Business
FDA Issues Emergency Authorization for Merck’s COVID-19 Treatment
Hackensack Meridian Health Supports Immuno-Oncology Platform
Pharma Execs Site Supply Chain Visibility To Boost Manufacturing
Pfizer to Amend Clinical Study of COVID-19 Vaccine in Children
FDA Approves ViiV Healthcare’s Long-Acting Injectable for HIV
FDA Approves Pfizer’s Drug to Treat Adult Patients With AS
Bristol Myers Squibb Partners for Bispecific T-Cell Candidate
Moderna’s COVID-19 Vaccine Booster Protects Against Omicron
Kite’s Yescarta Helps High-Risk Large B-Cell Lymphoma Patients
J&J’s CAR T-Cell Therapy Effective in Multiple Myeloma Patients
Pfizer to Acquire Arena to Boost Chronic Disease Management
CHMP Issues Positive Opinion of J&J’s COVID-19 Vaccine Booster
Roche Launches Platform to Advance Next-Generation Sequencing
J&J’s COVID-19 Vaccine Booster Increased Antibody, T-Cell Responses
AstraZeneca Enters Agreement for Transthyretin Amyloidosis Medicine
SAGE, WHO Support Johnson & Johnson COVID-19 Vaccine Booster
Moderna Launches Artificial Intelligence Academy for mRNA Therapies
GSK Welcomes Gavi Decision to Fund Routine Malaria Vaccines for Kids
Roche, TIB Molbiol Develop More COVID-19 Tests To Identify Variant
3 Doses of Pfizer’s COVID-19 Vaccine Neutralizes Omicron Variant
GSK, University of Oxford to Uncover Mechanisms of Disease
Thermo Fisher Introduces Protein To Advance CRISPR Gene Editing
GSK Initiative Addresses Key Challenges In Multiple Myeloma Care
FDA Approves Imaging Drug to Identify Ovarian Cancer
AstraZeneca Unveils $1B Research Facility To Advance Gene-Editing
J&J Considers Licensing COVID-19 Vaccine to South African Company
CVS Health Initiatives Increase Affordability, Access To Medicine
Specialty Drugs Accounted for Half of Medicaid Spending in 2020
Pfizer, AWS Collaborate To Improve Drug Development, Manufacturing
FDA Addresses Impacts of New Variant, Urges COVID-19 Vaccinations
Novo Nordisk Enters Pharma Acquisition Deal For RNAi Therapies
Moderna Doses First Patients in Phase 2 Study of mRNA RSV Vaccine
Johnson & Johnson Evaluates COVID-19 Vaccine Against New Variant